NCLT Mumbai approves a scheme for the demerger of Polybond (India)'s Medical Business into Eversure Medical, effective 1 April 2026.
The demerger rationale includes focused management, risk segregation, and optimized capital structure for both distinct businesses.
Meetings for shareholders and secured creditors are dispensed with due to 100% and 99.98% consent, respectively.
Unsecured creditors and regulatory authorities are to be notified but their meetings are also dispensed with by the Tribunal.